Moderna said its Covid-19 vaccine booster shot produced a “robust” antibody response against the highly contagious delta variant, according to details of a study released Thursday with the company’s second-quarter earnings report.
In a phase two trial, Moderna is testing a 50-microgram dose of three vaccine booster candidates in previously vaccinated individuals.
The booster shots produced a promising immune response against three variants, including delta, with antibody levels approaching those seen in previously unvaccinated people who received two 100-microgram doses, the company said.
Read the full article.
Moderna said its COVID-19 vaccine remained 93% effective six months after the second dose, and its COVID vaccine booster candidate produced a “robust” immune response against the delta variant. https://t.co/c1TEdQU97i
— Fox5NY (@fox5ny) August 5, 2021